Calithera Biosciences IPO Research Information

Calithera Biosciences IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Calithera Biosciences, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Calithera Biosciences	CALA - NASDAQ	$13.00-$15.00	$10.00	$10.22	8 million	10/2/2014
Underwriter(s): Citigroup, Leerink Partners
Co-Manager(s): Wells Fargo Securities, JMP Securities
Industry: Health Care
Filing(s): Filed 2014-08-25 Terms Added 2014-09-19

Calithera Biosciences Quote & Chart - Click for current quote - CALA

About Calithera Biosciences (adapted from Calithera Biosciences prospectus):
They are a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.

This description is adapted from Calithera Biosciences prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Calithera Biosciences "CALA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.